Powl Brian T. 4
4 · Kura Oncology, Inc. · Filed Jan 6, 2025
Insider Transaction Report
Form 4
Powl Brian T.
Chief Commercial Officer
Transactions
- Award
Option to purchase common stock
2025-01-02+92,500→ 92,500 totalExercise: $8.68Exp: 2035-01-01→ Common Stock (92,500 underlying) - Award
Common Stock
2025-01-02+46,250→ 61,250 total
Footnotes (2)
- [F1]Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/26, 1/26/27, 1/26/28 and 1/26/29.
- [F2]This option vests in 48 equal monthly installments commencing on the grant date.